NCT01513590 - A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes | Biotech Hunter

Enrollment

394

Participants

Timeline

Start Date

January 16, 2012

Primary Completion Date

November 19, 2012

Study Completion Date

November 19, 2012

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec/insulin aspart

Administered s.c. (under the skin) twice daily. Dose individually adjusted. Pre-trial metformin treatment to be continued.

Trial Locations (49)

1233

Novo Nordisk Investigational Site, Sofia

1431

Novo Nordisk Investigational Site, Sofia

1606

Novo Nordisk Investigational Site, Sofia

4002

Novo Nordisk Investigational Site, Plovdiv

5770

Novo Nordisk Investigational Site, Lukovit

6300

Novo Nordisk Investigational Site, Haskovo

7000

Novo Nordisk Investigational Site, Rousse

10000

Novo Nordisk Investigational Site, Zagreb

10002

Novo Nordisk Investigational Site, Zhytomyr

16000

Novo Nordisk Investigational Site, Algiers

19000

Novo Nordisk Investigational Site, Sétif

21010

Novo Nordisk Investigational Site, Vinnytsia

23000

Novo Nordisk Investigational Site, Zadar

31000

Novo Nordisk Investigational Site, Oran

34096

Novo Nordisk Investigational Site, Istanbul

34890

Novo Nordisk Investigational Site, Istanbul

36003

Novo Nordisk Investigational Site, Poltava

36011

Novo Nordisk Investigational Site, Poltava

41380

Novo Nordisk Investigational Site, Kocaeli

44869

Novo Nordisk Investigational Site, Bochum

47000

Novo Nordisk Investigational Site, Karlovac

49023

Novo Nordisk Investigational Site, Dnipro

50005

Novo Nordisk Investigational Site, Hradec Králové

65691

Novo Nordisk Investigational Site, Brno

66333

Novo Nordisk Investigational Site, Völklingen

66386

Novo Nordisk Investigational Site, Saint Ingbert-Oberwürzbach

66780

Novo Nordisk Investigational Site, Rehlingen-Siersburg

79010

Novo Nordisk Investigational Site, Lviv

88239

Novo Nordisk Investigational Site, Wangen

120203

Novo Nordisk Investigational Site, Buzău

410469

Novo Nordisk Investigational Site, Oradea

550176

Novo Nordisk Investigational Site, Sibiu

800578

Novo Nordisk Investigational Site, Galati

31 000

Novo Nordisk Investigational Site, Osijek

51 000

Novo Nordisk Investigational Site, Rijeka

100 00

Novo Nordisk Investigational Site, Prague

128 08

Novo Nordisk Investigational Site, Prague

06679

Novo Nordisk Investigational Site, Hohenmölsen

15-445

Novo Nordisk Investigational Site, Bialystok

20-044

Novo Nordisk Investigational Site, Lublin

20-538

Novo Nordisk Investigational Site, Lublin

09-400

Novo Nordisk Investigational Site, Mazowieckie

02-507

Novo Nordisk Investigational Site, Warsaw

020614

Novo Nordisk Investigational Site, Bucharest

821 02

Novo Nordisk Investigational Site, Bratislava

040 01

Novo Nordisk Investigational Site, Košice

07058

Novo Nordisk Investigational Site, Antalya

Unknown

Novo Nordisk Investigational Site, Istanbul

04114

Novo Nordisk Investigational Site, Kyiv